Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for ...
Guardant Health's Shield blood test for colorectal cancer screening is now covered by TRICARE, providing active duty service ...
Millions remain unscreened for colorectal cancer. Learn how noninvasive screening can expand access, preserve capacity, and ...
According to a 2025 survey conducted by the Prevent Cancer Foundation, only 51% of U.S. adults 21 and older say they have had ...
The U.S. Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older.The maker of the test, Palo Alto, California-based ...
FIT checks for blood in the stool, which can indicate the presence of colorectal cancer or polyps. Patients collect stool ...
A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...